2015-2019 Europe Pap Smear/HPV Market: Emerging Opportunities, Country Forecasts, Innovative Technologies, Competitive Landscape France, Germany, Italy, Spain, UK
Complete report $2,850. DataPack (test volumes, sales forecasts) $1,850. This report presents a detailed analysis of the Pap Smear/HPV testing market in Europe (France, Germany, Italy, Spain, UK), including clinical significance and current laboratory practice; as well as five-year test volume and sales forecasts by country and market segment. The report examines market applications of DNA probes, biochips/microarrays, monoclonal antibodies, immunoassays, IT, chromosome analysis, and other technologies; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks. The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer testing market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion worldwide. Contains 235 pages and 11 tables
I. INTRODUCTION
II. MYCOPLASMA WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Background
B. Diagnostic Tests
C. Vaccines and Drugs
D. Emerging Diagnostic Technologies
1. Molecular Diagnostics
2. Monoclonal Antibodies
3. Immunoassays
4. Differential Light Scattering
5. Information Technology
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. Diagnostic Imaging
11. Gel Microdroplets
12. Other
III. FRANCE: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
IV. GERMANY: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
V. ITALY: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
VI. JAPAN: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
VII. SPAIN: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
VIII. UK: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
IX. USA: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
W. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
XI. POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
XII. COMPETITIVE ASSESSMENTS
Abbott
Affymetrix
Beckman Coulter/Danaher
Becton Dickinson
bioMerieux
Bio - Rad
Cepheid
Diamedix/Erba
DiaSorin
Eiken Chemical
Elitech Group
Enzo Biochem
Fujirebio
Grifols
Hologic/Gen - Probe
ID Biomedical/GSK
Kreatech/Leica
Lonza
Ortho - Clinical Diagnostics
Qiagen
Roche
Scienion
Sequenom
SeraCare
Siemens
Takara Bio
Thermo Fisher
Wallac/PE
Wako
II. MYCOPLASMA WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Background
B. Diagnostic Tests
C. Vaccines and Drugs
D. Emerging Diagnostic Technologies
1. Molecular Diagnostics
2. Monoclonal Antibodies
3. Immunoassays
4. Differential Light Scattering
5. Information Technology
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. Diagnostic Imaging
11. Gel Microdroplets
12. Other
III. FRANCE: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
IV. GERMANY: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
V. ITALY: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
VI. JAPAN: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
VII. SPAIN: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
VIII. UK: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
IX. USA: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
W. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
XI. POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
XII. COMPETITIVE ASSESSMENTS
Abbott
Affymetrix
Beckman Coulter/Danaher
Becton Dickinson
bioMerieux
Bio - Rad
Cepheid
Diamedix/Erba
DiaSorin
Eiken Chemical
Elitech Group
Enzo Biochem
Fujirebio
Grifols
Hologic/Gen - Probe
ID Biomedical/GSK
Kreatech/Leica
Lonza
Ortho - Clinical Diagnostics
Qiagen
Roche
Scienion
Sequenom
SeraCare
Siemens
Takara Bio
Thermo Fisher
Wallac/PE
Wako
LIST OF TABLES
Major Companies Developing or Marketing Mycoplasma Tests
France Mycoplasma Test Volume and Diagnostics Sales Forecast by Market Segment
France Mycoplasma Testing Market Diagnostics Sales by Major Supplier
Germany Mycoplasma Test Volume and Diagnostics Sales Forecast by Market Segment
Germany Mycoplasma Testing Market Diagnostics Sales by Major Supplier
Italy Mycoplasma Test Volume and Diagnostics Sales Forecast by Market Segment
Italy Mycoplasma Testing Market Diagnostics Sales by Major Supplier
Japan Mycoplasma Test Volume and Diagnostics Sales Forecast by Market Segment
Japan Mycoplasma Testing Market Diagnostics Sales by Major Supplier
Spain Mycoplasma Test Volume and Diagnostics Sales Forecast by Market Segment
Spain Mycoplasma Testing Market Diagnostics Sales by Major Supplier
U.K. Mycoplasma Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Mycoplasma Testing Market Diagnostics Sales by Major Supplier
U.S.A. Mycoplasma Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Mycoplasma Testing Market Diagnostics Sales by Major Supplier
Major Companies Developing or Marketing Mycoplasma Tests
France Mycoplasma Test Volume and Diagnostics Sales Forecast by Market Segment
France Mycoplasma Testing Market Diagnostics Sales by Major Supplier
Germany Mycoplasma Test Volume and Diagnostics Sales Forecast by Market Segment
Germany Mycoplasma Testing Market Diagnostics Sales by Major Supplier
Italy Mycoplasma Test Volume and Diagnostics Sales Forecast by Market Segment
Italy Mycoplasma Testing Market Diagnostics Sales by Major Supplier
Japan Mycoplasma Test Volume and Diagnostics Sales Forecast by Market Segment
Japan Mycoplasma Testing Market Diagnostics Sales by Major Supplier
Spain Mycoplasma Test Volume and Diagnostics Sales Forecast by Market Segment
Spain Mycoplasma Testing Market Diagnostics Sales by Major Supplier
U.K. Mycoplasma Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Mycoplasma Testing Market Diagnostics Sales by Major Supplier
U.S.A. Mycoplasma Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Mycoplasma Testing Market Diagnostics Sales by Major Supplier
